A Phase 3 Telavancin Staphylococcus Aureus (S. Aureus) Bacteremia Trial

NCT02208063 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

121

Enrollment

INDUSTRY

Sponsor class

Stopped Halted due to lack of statistical power. No safety concerns identified.

Conditions

Bacteremia

Interventions

DRUG: Telavancin
DRUG: Vancomycin
DRUG: Daptomycin
DRUG: Synthetic penicillin
DRUG: Cefazolin

Sponsor

Cumberland Pharmaceuticals